ZURICH—Arthur Levinson has quit the board of Swiss pharmaceutical giant Roche Holding AG to focus on leading Google Inc.'s secretive Calico LLC life-sciences company.. The Basel-based cancer drugs maker said Thursday that Mr. Levinson, who served as CEO and chairman of Genentech, which Roche bought in 2009, left to avoid any conflict of interest.. While...
  